EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Management of laryngeal chondroradionecrosis: A single‐center experience

Einav G Levin iD, Amit Ritter iD, Gideon Bachar, Aviram Mizrachi, Hagit Shoffel-Havakuk, Noga Kurman, Aron Popovtzer, Yaniv Hamzany

Head & Neck · 2025-01 · 47 (1) · 300-308

DOI: 10.1002/hed.27919 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, online erschienen am 13.08.2024. Verfasst von Einav G Levin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology - Head and Neck Surgery, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, Hyperbaric Oxygenation, Radiation Injuries. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Laryngeal chondroradionecrosis (LCRN) is a rare but severe complication of radiation therapy. The study aimed to review the management of LCRN and evaluate the clinical benefit of hyperbaric oxygen therapy (HBOT).

Methods

We retrospectively analyzed all radiation‐induced LCRN patients between 2006 and 2019 at a tertiary medical center. Diagnosis was based on signs and symptoms of Chandler's classification, imaging, and/or histopathology report. The primary outcome was improvement in Chandler's grade after HBOT.

Results

Of 678 irradiated laryngeal cancer patients, 29 (4.3%) were diagnosed with LCRN. The most common primary management was tracheostomy with intravenous steroids and antibiotics (59%). Ten patients received HBOT (34.5%), and six underwent total laryngectomy (21%). In HBOT‐treated patients, Chandler's grade significantly improved from a median of 4 (range 2–4) to 2.5 (range 1–4; p = 0.005).

Conclusions

HBOT may benefit in the management of patients with persistence and unresponsive symptoms of LCRN following radiation therapy for laryngeal SCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Laryngeal NeoplasmsHyperbaric OxygenationRadiation InjuriesHumansMaleRetrospective StudiesFemaleMiddle AgedAgedLaryngectomyTracheostomyLaryngeal DiseasesAged, 80 and overAdultTreatment Outcome

Stichwörter der Autor:innen

chondroradionecrosishyperbaric oxygen therapylarynxradiation‐induced complications

Autor:innen und Institutionen

  • Department of Otolaryngology - Head and Neck Surgery, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.
  • Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel.

ORCID-Profile: Einav G Levin, Amit Ritter

Zitieren

APA

Levin, E. G., Ritter, A., Bachar, G., Mizrachi, A., Shoffel-Havakuk, H., Kurman, N., Popovtzer, A., & Hamzany, Y. (2025). Management of laryngeal chondroradionecrosis: A single‐center experience. Head & Neck, 47(1), 300-308. https://doi.org/10.1002/hed.27919

Vancouver

Levin EG, Ritter A, Bachar G, Mizrachi A, Shoffel-Havakuk H, Kurman N, et al. Management of laryngeal chondroradionecrosis: A single‐center experience. Head & Neck. 2025;47(1):300-308. doi:10.1002/hed.27919

BibTeX
@article{Levin2025,
  author = {Levin, Einav G and Ritter, Amit and Bachar, Gideon and Mizrachi, Aviram and Shoffel-Havakuk, Hagit and Kurman, Noga and Popovtzer, Aron and Hamzany, Yaniv},
  title = {Management of laryngeal chondroradionecrosis: A single‐center experience},
  journal = {Head & Neck},
  year = {2025},
  volume = {47},
  number = {1},
  pages = {300--308},
  doi = {10.1002/hed.27919}
}
Kostenlos starten →